Terms: = Pancreatic cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
19 results:
1. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of tertiary lymphoid structures (tls) in digestive system cancers: a systematic review and meta-analysis.
Sun H; Shi Y; Ran H; Peng J; Li Q; Zheng G; He Y; Liu S; Chang W; Xiao Y
BMC Cancer; 2023 Dec; 23(1):1248. PubMed ID: 38110876
[TBL] [Abstract] [Full Text] [Related]
3. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
[TBL] [Abstract] [Full Text] [Related]
5. pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies.
Senturk ZN; Akdag I; Deniz B; Sayi-Yazgan A
Front Immunol; 2023; 14():1152551. PubMed ID: 37033931
[TBL] [Abstract] [Full Text] [Related]
6. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Ono T; Akiyama T; Hirabayashi K; Ozawa I; Nakagawa R; Kikuta K; Kondo T
Hum Cell; 2022 Jul; 35(4):1279-1289. PubMed ID: 35637403
[TBL] [Abstract] [Full Text] [Related]
7. fus-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
[TBL] [Abstract] [Full Text] [Related]
8. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved prognosis in Patients With Hepatocellular Carcinoma.
Li H; Liu H; Fu H; Li J; Xu L; Wang G; Wu H
Front Immunol; 2021; 12():648812. PubMed ID: 34122408
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
Noguchi R; Yoshimatsu Y; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):667-674. PubMed ID: 33146842
[TBL] [Abstract] [Full Text] [Related]
10. Evidencing a pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.
Fraunhoffer NA; Abuelafia AM; Bigonnet M; Gayet O; Roques J; Telle E; Santofimia-Castaño P; Borrello MT; Chuluyan E; Dusetti N; Iovanna J
Clin Cancer Res; 2020 Oct; 26(20):5506-5519. PubMed ID: 32669378
[TBL] [Abstract] [Full Text] [Related]
11. Type II enteropathy-associated T cell lymphoma in the duodenum: A rare case report.
Liu Z; He L; Jiao Y; Wang H; Suo J
Medicine (Baltimore); 2020 Jun; 99(23):e20050. PubMed ID: 32501967
[TBL] [Abstract] [Full Text] [Related]
12. Chloroquine induces apoptosis in pancreatic neuroendocrine neoplasms via endoplasmic reticulum stress.
Nakano K; Masui T; Yogo A; Uchida Y; Sato A; Kasai Y; Nagai K; Anazawa T; Kawaguchi Y; Uemoto S
Endocr Relat Cancer; 2020 Jul; 27(7):431-439. PubMed ID: 32369772
[TBL] [Abstract] [Full Text] [Related]
13. Primary pancreatic lymphoma: a rare clinical entity.
Dunphy L; Abbas SH; Al Shoek I; Al-Salti W
BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31907215
[TBL] [Abstract] [Full Text] [Related]
14. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis.
Chang WT; Fong Y; Chuang SC; Chou CK; Chou HL; Yang CF; Tseng CH; Chen YL; Chiu CC
Anticancer Agents Med Chem; 2017; 17(5):692-700. PubMed ID: 27491935
[TBL] [Abstract] [Full Text] [Related]
15. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
Peng W; Wu J; Feng J
Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
[TBL] [Abstract] [Full Text] [Related]
16. Bitter melon juice activates cellular energy sensor AMP-activated protein kinase causing apoptotic death of human pancreatic carcinoma cells.
Kaur M; Deep G; Jain AK; Raina K; Agarwal C; Wempe MF; Agarwal R
Carcinogenesis; 2013 Jul; 34(7):1585-92. PubMed ID: 23475945
[TBL] [Abstract] [Full Text] [Related]
17. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
Wissniowski TT; Meister S; Hahn EG; Kalden JR; Voll R; Ocker M
Int J Oncol; 2012 May; 40(5):1581-9. PubMed ID: 22266985
[TBL] [Abstract] [Full Text] [Related]
18. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum.
Gajate C; Matos-da-Silva M; Dakir el-H; Fonteriz RI; Alvarez J; Mollinedo F
Oncogene; 2012 May; 31(21):2627-39. PubMed ID: 22056873
[TBL] [Abstract] [Full Text] [Related]
19. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience.
Yun J; Kim SJ; Kim JA; Kong JH; Lee SH; Kim K; Ko YH; Kim WS
Acta Haematol; 2010; 123(1):48-54. PubMed ID: 19955711
[TBL] [Abstract] [Full Text] [Related]
